[Fibrinolytic therapy. Report on 5 year experience].
D000208:Acute Disease; D000925:Anticoagulants / Q000627:therapeutic use; D001132:Arm / Q000098:blood supply; D001158:Arteries; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D002561:Cerebrovascular Disorders / Q000188:drug therapy; D003327:Coronary Disease / Q000188:drug therapy; D004562:Electrocardiography; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007866:Leg / Q000098:blood supply; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D010477:Perfusion; D013300:Streptokinase / Q000494:pharmacology; D013924:Thrombophlebitis / Q000188:drug therapy; D013997:Time Factors; D014652:Vascular Diseases / Q000188:drug therapy
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D013300:Streptokinase
Fibrinolytische Therapie. Erfahrungsbericht übe fünf Jahre.